Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
June 2023
in “
Cancers
”
immune checkpoint inhibitors targeted therapies maculopapular rash lichenoid rash psoriasiform rash autoimmune bullous disorders PD-1 inhibitors PD-L1 inhibitors pruritus vitiligo CTLA-4 inhibitors alopecia areata telogen effluvium MEK-Inhibitors papulopustular eruption xerosis Hedgehog-Inhibitors alopecia Stevens–Johnson syndrome toxic epidermal necrolysis AGEP DRESS SJS TEN
Studysummary This article reviews the cutaneous side effects of immune checkpoint inhibitors and targeted therapies for skin cancers, noting that while generally mild, these effects can influence treatment decisions and quality of life, underscoring the need for physicians to be aware of these adverse reactions.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on mdpi.com →